Physician profile
Amy Rivas
NPI 1699244830
$16,885.99
in general payments reported to CMS, 2019-2025
52 companies · $7,716 in 2025
The $7,716 reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,708 · 2022: $1,747 · 2023: $1,023 · 2024: $4,691 · 2025: $7,716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $1,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,244.26 |
| Travel and Lodging | $1,186.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $3,796.23 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Medtronic, INC. | $2,573.03 | 2023-2025 | Minimed 780g, Inpen Smart Insulin Delivery System, Signia |
| Lilly USA, LLC | $1,493.34 | 2021-2025 | Zepbound, Jardiance, Mounjaro |
| Corcept Therapeutics | $842.29 | 2024-2025 | Korlym |
| Sequel Med Tech, LLC | $746.34 | 2025 | Twiist |
| Abbott Laboratories | $599.82 | 2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $575.43 | 2024-2025 | Jardiance, Synjardy, Tradjenta |
| Amgen INC. | $530.24 | 2024-2025 | Tepezza, Repatha, Evenity |
| Ascensia Diabetes Care US INC. | $433.80 | 2024-2025 | |
| Radius Health, INC. | $379.75 | 2024-2025 | Tymlos |
| Insulet Corporation | $376.52 | 2025 | Omnipod |
| Madrigal Pharmaceuticals | $349.02 | 2025 | Rezdiffra |
| Novartis Pharmaceuticals Corporation | $314.33 | 2024-2025 | |
| Cequr Corporation | $238.62 | 2024-2025 | Cequr Simplicity |
| Kyowa Kirin, INC. | $234.70 | 2024-2025 | Crysvita |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $220.80 | 2021-2023 | Movantik, Talicia, Aemcolo |
| Beta Bionics, INC. | $215.80 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Alexion Pharmaceuticals, INC. | $210.16 | 2024-2025 | Strensiq |
| Tandem Diabetes Care, INC. | $197.79 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Currax Pharmaceuticals LLC | $177.23 | 2021-2023 | Contrave |
| Silk Road Medical, INC. | $165.15 | 2021 | |
| Rhythm Pharmaceuticals, INC. | $159.41 | 2022-2025 | Imcivree, Imcivree |
| Si-Bone, INC. | $147.06 | 2021 | |
| Lucid Diagnostics INC. | $140.17 | 2022-2023 | |
| Recordati_rare_diseases_inc. | $137.54 | 2024-2025 | Signifor Lar, Isturisa |
| Ipsen Biopharmaceuticals, INC | $126.62 | 2024-2025 | Iqirvo, Onivyde |
| Inari Medical, INC. | $125.00 | 2022 | |
| Dexcom, INC. | $124.99 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $114.96 | 2024-2025 | |
| Neurocrine Biosciences, INC. | $114.84 | 2024-2025 | |
| Soleno Therapeutics, INC. | $112.50 | 2025 | Vykat Xr |
| Itamar Medical INC | $94.97 | 2024 | Watchpatone |
| Abiomed | $92.98 | 2021 | |
| Vivus LLC | $76.14 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $75.54 | 2024-2025 | Gvoke Hypopen, Recorlev |
| Astrazeneca Pharmaceuticals LP | $71.11 | 2022 | |
| Almatica Pharma LLC | $63.83 | 2024-2025 | Teriparatide |
| Abbvie INC. | $62.46 | 2024-2025 | |
| Daiichi Sankyo INC. | $54.10 | 2021 | |
| Ascendis Pharma Endocrinology INC | $45.49 | 2023 | |
| Baxter Healthcare | $41.12 | 2022 | |
| Janssen Biotech, INC. | $38.63 | 2025 | Darzalex, Talvey, Tecvayli |
| Endo Pharmaceuticals INC. | $36.30 | 2021 | |
| Fisher & Paykel Healthcare INC | $25.62 | 2023 | Fisher & Paykel Healthcare |
| Glaxosmithkline, LLC. | $20.84 | 2025 | Shingrix, Arexvy |
| Takeda Pharmaceuticals U.S.A., INC. | $18.82 | 2022 | |
| Averitas Pharma INC. | $17.16 | 2025 | Qutenza |
| Innocoll Pharmaceuticals Limited | $16.45 | 2021 | |
| Esperion Therapeutics, INC. | $16.23 | 2024 | Nexletol |
| Eagle Pharmaceuticals, INC. | $15.19 | 2022 | |
| Davol INC. | $14.92 | 2023 | Arista Ah Flexitip |
| Lsi Solutions INC | $14.61 | 2023 | Running Device |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Rivas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.